Search results
OS Therapies Inc. Plans $8 Million IPO for June 20th (OSTX)
ETF DAILY NEWS· 2 days agoOS Therapies Inc. (OSTX) plans to raise $8 million in an IPO on Thursday, June 20th, IPO Scoop reports. The company will issue 2,000,000 shares at a price of $4.00 per share. OS Therapies Inc. has a market cap of $82.3 million.
Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Up 191.7% in May
ETF DAILY NEWS· 4 days agoDominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,500 ...
Entrada Therapeutics (NASDAQ:TRDA) versus BioLineRx (NASDAQ:BLRX) Head to Head Comparison
ETF DAILY NEWS· 3 days agoBioLineRx (NASDAQ:BLRX – Get Free Report) and Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast ...
One Patient Changed This Onc's View of Hope. Here's How.
Medscape· 5 days agoOne Patient Changed This Oncologist's View of Hope. Following a stem cell transplant for leukemia,...
AbbVie inks deal to develop new IBD therapy with FutureGen By Investing.com
Investing.com· 4 days agoFG-M701, which is currently in the preclinical development stage, is designed as a fully human...
Hiker in cardiac distress rescued from Great Smoky Mountains National Park
WATE 6 Knoxville· 3 days agoA Tennessee National Guard flight crew rescued a hiker in cardiac distress from the Great Smoky...
Pastor John ‘Crayola Man’ dies after years of serving Knox County community
WATE 6 Knoxville· 20 hours agoPastor John Unthank died on June 16 after several years of serving the Knox County community.
The reigning Miss America is an active-duty Air Force soldier with big dreams
The Post and Courier· 5 days agoIt’s a question Marsh works to answer every day. Now, she researches the disease to help improve ...
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory...
The Port Lavaca Wave· 4 days ago- Global license agreement to focus on the development of FG-M701, a TL1A antibody, for the treatment of inflammatory bowel disease (IBD)
NC bill advances to force Chemours, others to pay for harm done to drinking water by PFAS
Durham Herald-Sun via Yahoo News· 5 days agoA Chemours representative asked that the bill not advance out of committee, saying the company built...